Koios Beverage (CSE:KBEV, OTC:SNOVF) (the “Company” or “Koios”) is pleased to announce it will begin production of a new line of functional beverages under the brand ‘Fit Soda’, beginning in Q1 of 2019.

Fit Soda is a new line of functional beverages being produced by Koios Beverage Corp., providing both great taste and health benefits. Essentially, it's a 'Soda with Benefits!" (CNW Group/Koios Beverage Corp.)
Fit Soda is a new line of functional beverages being produced by Koios Beverage Corp., providing both great taste and health benefits. Essentially, it’s a ‘Soda with Benefits!” (CNW Group/Koios Beverage Corp.)

A functional beverage is a drink augmented with nutrients and/or supplements in order to convey a health benefit to the consumer. Examples of functional beverages include sports and performance drinks, ready to drink (RTD) teas, and nootropic beverages sometimes known as ‘smart drinks’.


Koios is already one of the leading innovators in the nootropic beverage industry, and is now branching out into a line of functional soda drinks.

“This is a beverage line we’ve had in our development pipeline since before we launched the company,” says Koios CEO Chris Miller. “We wanted to produce a beverage that lets our customers enjoy a high end soda drink, but also get some benefit from that drink at the same time.”

Fit Soda will be produced using only organic ingredients and manufacturing methods, without any artificial preservatives, colours or flavours.

“The idea is to create a beverage that gives you all the taste you expect from a quality soda product, but with none of the guilt,” Miller says. “It’s a ‘soda with benefits’.”

The Fit Soda line is the second phase of the Koios product launch that began in early 2018 with the production of the Company’s line of nootropic beverages intended to increase mental focus and acuity. The Fit Soda line is generally focused more on physical well being, featuring blends that offer high levels of nutrients, amino acids, proteins, electrolytes or probiotics.

“Our society is experiencing huge demand for natural, organic foods and beverages, with the market for these products growing by an expected 70 per cent between 2016 and 2021,” Miller says. (Source: Packaged Facts, 2016) “We’re seeing that demand already, as our sales literally doubled over last month.”

To meet that growth, Koios announced in August it had entered into a co-packaging agreement with Golden Global Goods, the parent company of Rocky Mountain Soda.  The agreement gives Koios access to Rocky Mountain’s high-volume production line, so the functional beverage maker can now produce a lower minimum amount of product at any given time, while achieving the same cost-effectiveness that could otherwise only be gained through mass production.

Miller says that agreement was reached in part so that Koios can schedule release of its Fit Soda line in January or February of 2019, while still maintaining production of its current lines of nootropic beverages.

Additionally, the Company will also proceed with its new line of THC and CBD infused beverages through its wholly owned subsidiary Cannavated Beverage Corp., as announced on Sept. 4, 2018.

On behalf of the Board of Directors of the Company.

Chris Miller, CEO and Director, KOIOS BEVERAGE CORP.

About Koios Beverage Inc.
The Company, through its wholly-owned subsidiary Koios, Inc., is an emerging functional beverage company which has an available distribution network of more than 2,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well.  Koios is also the sole owner of Cannavated Beverage Co., a subsidiary that develops beverage products and formulas for the growing cannabis market. Through its agreement with Keef Brands, the largest producer of cannabis beverages in North America, Cannavated enjoys distribution throughout the State of Colorado and is preparing for distribution in additional US states where cannabis use is legal.

Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants.  Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity.  Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.

Koios is one of the only drinks in the world to infuse its products with MCT oil.  MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.mentaltitan.com/ or koiosbeveragecorp.com

Forward-Looking Statements
This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding the timing for release of a new product line, and figures from a 2016 study by Packaged Facts on the future demand for natural and organic foods and beverages. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include general market conditions and other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

Koios has not conducted any scientific studies on the effects of Koios’ products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios’ products will vary from person to person. No claims or guarantees can be made as to the effects of Koios’ products on an individual’s health and wellbeing.

For further information: Paula Arab, 403.889.9128, paula.arab@koiosbeveragecorp.com

Click here to connect with Koios Beverage (CSE:KBEV, OTC:SNOVF) for an Investor Presentation.

Source: www.newswire.ca

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less